Blog
Celsius Holdings' Q3 Revenues Hit $725M: Will the Momentum Last?
Celsius Holdings, Inc. (CELH) delivered another robust performance, with third-quarter 2025 revenues surging 173% year over year to $725.1 million. The big driver was the addition of new brands and
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The easiest way to judge
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.
How can
AES Gains Momentum From Renewable Energy Expansion and LNG Growth
The AES Corporation AES is accelerating its renewable energy generation by expanding its solar, wind and battery storage capacities to meet long-term clean energy targets. Simultaneously, the
4 Value Stocks Primed for Gains as Shutdown Uncertainty Fades
Wall Street took a sigh of relief after the U.S. Senate took measures to resolve the prolonged government shutdown. The move was seen as a key step toward restoring access to official data that had
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
Penumbra, Inc. PEN reported third-quarter 2025 adjusted earnings per share (EPS) of 97 cents, which surpassed the Zacks Consensus Estimate by 7.78%. Adjusted EPS improved 14.1% year over year.
GAAP
CVS Health Lifts Adjusted EPS Outlook: What's Driving It?
CVS Health CVS posted a strong third quarter, delivering a 47% year-over-year increase in adjusted earnings per share (EPS) to $1.60. Revenues reached a record $103 billion, up roughly 8% from last
Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release?
Last week, Tempus AI Inc. TEM reported its third-quarter 2025 results. Both earnings and revenues beat their respective consensus estimate.
Tempus, a technology company leading the adoption of
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up
Veracyte, Inc. VCYT delivered third-quarter 2025 adjusted earnings of 51 cents per share, which marked a stupendous improvement of 54.5% from the year-ago period’s figure of 33 cents. The bottom
Worried About US Market Volatility? Explore These Japanese ETFs
For investors concerned about increasing volatility in the U.S. stock market, Japanese equities offer a compelling alternative. In recent months, Japan's stock market has not only outperformed that
$1 Trillion Holiday Season Sales Haul: ETFs to Gain Momentum
As the holiday season approaches, the retail sector transforms into a powerful engine for the U.S. stock market. This period traditionally fuels significant revenue surges for companies ranging from
SONY Q2 Earnings & Revenues Rise Y/Y, View Up on G&NS & Music Momentum
Sony Group Corporation (SONY) reported second-quarter fiscal 2025 net income per share (on a GAAP basis) of ¥51.71, up from ¥48.04 in the year-ago quarter. Adjusted net income came in at ¥311.4
Chemours Q3 Earnings Lag Estimates Amid Operational Disruptions
The Chemours Company CC reported a net income of $60 million or 40 cents per share for the third quarter of 2025. This compares favorably with the year-ago quarter's net loss of $32 million or 22
Is Franklin Utilities A1 (FKUTX) a Strong Mutual Fund Pick Right Now?
Sector - Utilities fund seekers should consider taking a look at Franklin Utilities A1 (FKUTX). FKUTX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors
Is PDINX a Strong Bond Fund Right Now?
Looking for a Diversified Bonds fund? You may want to consider Putnam Diversified Income A (PDINX) as a possible option. PDINX bears a Zacks Mutual Fund Rank of 3 (Hold), which is based on various
Is T. Rowe Price Personal Strategy Income (PRSIX) a Strong Mutual Fund Pick Right Now?
If you've been stuck searching for Allocation Balanced funds, consider T. Rowe Price Personal Strategy Income (PRSIX) as a possibility. PRSIX bears a Zacks Mutual Fund Rank of 2 (Buy), which is
Is USAIX a Strong Bond Fund Right Now?
Having trouble finding a Investment Grade Bond - Intermediate fund? Victory Income (USAIX) is a potential starting point. USAIX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on
Is Vanguard LifeStrategy Income Fund (VASIX) a Strong Mutual Fund Pick Right Now?
If investors are looking at the Allocation Balanced fund category, make sure to pass over Vanguard LifeStrategy Income Fund (VASIX). VASIX has a Zacks Mutual Fund Rank of 4 (Sell), which is based on
Polar Blast to Warm Up Natural Gas ETFs This Winter?
Natural gas prices are likely to bask in the glow of winter chills this season. The likelihood of extreme cold gripping the United States, Asia, and parts of Europe is climbing. There are signs that
New Strong Sell Stocks for Nov. 11
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
DENTSPLY SIRONA Inc. XRAY is a dental and healthcare products company. The Zacks Consensus Estimate for its current year
New Strong Buy Stocks for Nov. 11: HOOD, TCMD, and More
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Tactile Systems Technology, Inc. TCMD: This medical technology company has seen the Zacks Consensus Estimate for its current
Should You Invest in the State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP)?
Launched on June 19, 2006, the State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP) is a passively managed exchange traded fund designed to provide a broad exposure to the Energy -
Should Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) Be on Your Investing Radar?
Designed to provide broad exposure to the Mid Cap Growth segment of the US equity market, the Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) is a passively managed exchange traded fund launched on
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
What Are



